Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2020		73,314,026,000
Beginning balance at Dec. 31, 2020	$ 300,252	$ 7	$ 369,467	$ (69,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,284,977,000
Issuance of common stock upon exercise of stock options	2,932		2,932
Issuance of common stock upon settlement of restricted stock units (in shares)		6,446,000
Exercise of common stock warrants (in shares)		72,407,000
Stock-based compensation expense	30,828		30,828
Shares withheld related to net share settlement of restricted stock units (in shares)		(1,730,000)
Shares withheld related to net share settlement of restricted stock units	(236)		(236)
Issuance of common stock in connection with acquisition	71,003		71,003
Issuance of common stock in connection with an acquisition (in shares)		650,740,000
Issuance of common stock in connection with follow-on offering, net of underwriting discounts, commissions, and offering costs (in shares)		2,300,000,000
Issuance of common stock in connection with follow-on offering, net of underwriting discounts, commissions, and offering costs	263,931	$ 1	263,930
Net income	47,386			47,386
Ending balance (in shares) at Jun. 30, 2021		77,626,866,000
Ending balance at Jun. 30, 2021	716,096	$ 8	737,924	(21,836)
Beginning balance (in shares) at Mar. 31, 2021		73,908,252,000
Beginning balance at Mar. 31, 2021	320,590	$ 7	379,703	(59,120)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		763,466,000
Issuance of common stock upon exercise of stock options	1,440		1,440
Issuance of common stock upon settlement of restricted stock units (in shares)		6,138,000
Stock-based compensation expense	22,084		22,084
Shares withheld related to net share settlement of restricted stock units (in shares)		(1,730,000)
Shares withheld related to net share settlement of restricted stock units	(236)		(236)
Issuance of common stock in connection with acquisition	71,003		71,003
Issuance of common stock in connection with an acquisition (in shares)		650,740,000
Issuance of common stock in connection with follow-on offering, net of underwriting discounts, commissions, and offering costs (in shares)		2,300,000,000
Issuance of common stock in connection with follow-on offering, net of underwriting discounts, commissions, and offering costs	263,931	$ 1	263,930
Net income	37,284			37,284
Ending balance (in shares) at Jun. 30, 2021		77,626,866,000
Ending balance at Jun. 30, 2021	$ 716,096	$ 8	737,924	(21,836)
Beginning balance (in shares) at Dec. 31, 2021	83,659,665	83,659,665,000
Beginning balance at Dec. 31, 2021	$ 807,078	$ 8	740,849	66,221
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,804,373,000	1,804,373,000
Issuance of common stock upon exercise of stock options	$ 9,407	$ 1	9,406
Issuance of common stock upon settlement of restricted stock units (in shares)		179,878,000
Stock-based compensation expense	58,376		58,376
Issuance of common stock under employee stock purchase plan (in shares)		47,894,000
Issuance of common stock under employee stock purchase plan	4,431		4,431
Stock repurchased during period (in shares)		(3,503,438,000)
Repurchases of stock	(125,042)	$ (1)	(125,041)
Net income	$ 2,821			2,821
Ending balance (in shares) at Jun. 30, 2022	82,188,372	82,188,372,000
Ending balance at Jun. 30, 2022	$ 757,071	$ 8	688,021	69,042
Beginning balance (in shares) at Mar. 31, 2022		84,676,746,000
Beginning balance at Mar. 31, 2022	876,504	$ 9	777,582	98,913
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		915,412,000
Issuance of common stock upon exercise of stock options	3,781		3,781
Issuance of common stock upon settlement of restricted stock units (in shares)		99,652,000
Stock-based compensation expense	31,699		31,699
Stock repurchased during period (in shares)		(3,503,438,000)
Repurchases of stock	(125,042)	$ (1)	(125,041)
Net income	$ (29,871)			(29,871)
Ending balance (in shares) at Jun. 30, 2022	82,188,372	82,188,372,000
Ending balance at Jun. 30, 2022	$ 757,071	$ 8	$ 688,021	$ 69,042